What is Palisade Bio, Inc. Common Stock's Market Cap?

Palisade Bio, Inc. Common Stock's Market Cap is $362.5M, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's Price / Sales?

Palisade Bio, Inc. Common Stock's Price / Sales is 724965521.3×, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's Revenue (TTM)?

Palisade Bio, Inc. Common Stock's Revenue (TTM) is $0.50, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's Net Income (TTM)?

Palisade Bio, Inc. Common Stock's Net Income (TTM) is -$31.9M, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's EBITDA?

Palisade Bio, Inc. Common Stock's EBITDA is -$35.3M, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's Diluted EPS (TTM)?

Palisade Bio, Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.

What is Palisade Bio, Inc. Common Stock's EBITDA Margin?

Palisade Bio, Inc. Common Stock's EBITDA Margin is -7069600000.0%, based on as-reported figures from SEC (XBRL) filings.

Palisade Bio, Inc. Common Stock (PALI) Financial Statements

Palisade Bio, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001SS4KZ8

XNAS · usd

2.08▼ 0.12 (-5.45%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close2.20

Day's Range2.08 – 2.24

52-Week Range0.53 – 2.86

Volume3.5M

Avg Volume1.6M

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2021-04-28

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Palisade Bio, Inc. Common Stock (PALI)

What is Palisade Bio, Inc. Common Stock's Market Cap?: Palisade Bio, Inc. Common Stock's Market Cap is $362.5M, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's Price / Sales?: Palisade Bio, Inc. Common Stock's Price / Sales is 724965521.3×, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's Revenue (TTM)?: Palisade Bio, Inc. Common Stock's Revenue (TTM) is $0.50, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's Net Income (TTM)?: Palisade Bio, Inc. Common Stock's Net Income (TTM) is -$31.9M, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's EBITDA?: Palisade Bio, Inc. Common Stock's EBITDA is -$35.3M, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's Diluted EPS (TTM)?: Palisade Bio, Inc. Common Stock's Diluted EPS (TTM) is -0.18, based on as-reported figures from SEC (XBRL) filings.
What is Palisade Bio, Inc. Common Stock's EBITDA Margin?: Palisade Bio, Inc. Common Stock's EBITDA Margin is -7069600000.0%, based on as-reported figures from SEC (XBRL) filings.